EMJ

Is your first-line approach to rheumatoid arthritis still up to date? Rheumatology experts discuss current treatment approaches, how to choose first-line therapy, and recent advances in clinical practice. Watch the Webinar: https://lnkd.in/dGCQEbMy/?utm_campaign=30/10/26-EMJ-MED-RHE-013-25-1&utm_source=linkedin&utm_medium=paid&utm_id=1245179643&hsa_acc=513039160&hsa_cam=1245179643&hsa_grp=898004023&hsa_ad=1603541873&hsa_net=linkedin&hsa_ver=3 Prescribing information for Metoject® PEN (methotrexate) is available here: https://lnkd.in/dNAYWFCf/?utm_campaign=30/10/26-EMJ-MED-RHE-013-25-1&utm_source=linkedin&utm_medium=paid&utm_id=1245179643&hsa_acc=513039160&hsa_cam=1245179643&hsa_grp=898004023&hsa_ad=1603541873&hsa_net=linkedin&hsa_ver=3. Please consult your local prescribing information as information may vary. Adverse event reporting information can be found at the bottom of this webpage.

HCP content underperforming? The usual fixes: → Rewrite the message → Push it to more people But if the science is sound and the audience is right, the message isn’t the problem. The format is. Clinicians have minutes, not hours. A long article or 50-minute recording makes them dig for what’s relevant. Many won’t. Not because the evidence lacks value, but because it takes too long to reach. What helps: formats that let them choose their own path. Skim the highlights Go deeper where it matters Test what they know We compared static and interactive versions of the same article. Only the format changed: 3x the page views 180% more engaged sessions Before reworking the science, look at how it’s delivered.

Young infants remain the most vulnerable to severe pertussis. But what we know about protecting them has shifted. There’s new evidence on maternal immunisation, waning immunity, disease burden, and the coverage and delivery gaps that leave infants exposed. A decade after its last recommendations, the Global Pertussis Initiative has reviewed that evidence and set out a risk-based framework to help countries adapt their vaccination policies.¹ The evidence has moved on. Is it time policy did too? #Pertussis #Immunisation #GlobalHealth #VaccinationInPregnancy 1. Ong-Lim A, et al. Pertussis vaccination in a changing landscape: considerations for future policy. SSRN. 2026. Available at: https://lnkd.in/dUy2PPR8/?utm_campaign=23/10/26-EMJ-SAN-MIC-013-26-1&utm_source=linkedin&utm_medium=paid&utm_id=1237738203&hsa_acc=513039160&hsa_cam=1237738203&hsa_grp=897230793&hsa_ad=1592652893&hsa_net=linkedin&hsa_ver=3 This content was supported by Sanofi, which had no influence or control over its editorial content. Intended for healthcare professionals.

Discover how 25 years of progress in chronic myeloid leukemia (CML) are shaping the future of patient care. In this video from the European Hematology Association (EHA) Congress 2026, Dr. Koji Sasaki explores the latest clinical data from a clinical trial, the evolving focus on quality of life for patients with CML, and the potential role of digital tools and AI in advancing care. Watch the latest video now. This podcast has been supported by Novartis. This video is intended for healthcare professionals only and is not intended for the general public. Please refer to the latest local Prescribing Information applicable in your country. #Hematology #CML #ChronicMyeloidLeukemia #EHA2026

Six figures. Months of preparation. 30 minutes in one room. Then the delegates walk out, and your symposium's reach walks out with them. Our latest insight piece shows you how to turn a one-day audience into a lasting one: → How to extend the life of your congress content well beyond the session itself → Why the weeks after congress are your biggest window for impact → How to reach the specialists who couldn't be in the room Learn how to make your next symposium work harder.

Only 17% of HCPs give an email their full attention - most skim, save for later, or delete. Discover new research on healthcare professionals inbox habits, and find out what actually earns engagement.